NASDAQ : ETON
Eton Pharmaceuticals, Inc. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 53.67 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.53B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.49B |
| Enterprise Value | 1.49B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 28.58M |
| Shares Outstanding | 28.58M |
| Shares Change (YoY) | +11.94% |
| Shares Change (QoQ) | +3.93% |
| Owned by Insiders (%) | 4.93% |
| Owned by Institutions (%) | 54.60% |
| Float | 22.30M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 121.91 |
| Forward PE | 35.44 |
| PS Ratio | 14.12 |
| Forward PS | 7.72 |
| PB Ratio | 31.69 |
| P/TBV Ratio | 1,644.40 |
| P/FCF Ratio | 101.24 |
| P/OCF Ratio | 98.54 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 117.74 |
| EV / Sales | 14.15 |
| EV / EBITDA | 59.33 |
| EV / EBIT | 72.39 |
| EV / FCF | 101.40 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.52 |
| Quick Ratio | 1.15 |
| Debt / Equity | 0.63 |
| Debt / EBITDA | 1.15 |
| Debt / FCF | 1.98 |
| Interest Coverage | 4.52 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 35.97% |
| Return on Assets (ROA) | 11.86% |
| Return on Invested Capital (ROIC) | 45.04% |
| Return on Capital Employed (ROCE) | 29.19% |
| Weighted Average Cost of Capital (WACC) | 9.32% |
| Revenue Per Employee | $2.40M |
| Profits Per Employee | $288,364 |
| Employee Count | 44 |
| Asset Turnover | 0.97 |
| Inventory Turnover | 2.40 |
Taxes
| Measure | Value |
|---|
| Income Tax | 63,000 |
| Effective Tax Rate | 0.49% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.90 |
| 52-Week Price Change | +184.98% |
| 50-Day Moving Average | 56.00 |
| 200-Day Moving Average | 35.71 |
| Relative Strength Index (RSI) | 47.89 |
| Average Volume (20 Days) | 412,565 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.94M |
| Short Previous Month | 1.83M |
| Short % of Shares Out | 6.80% |
| Short % of Float | 8.72% |
| Short Ratio (days to cover) | 3.18 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 105.60M |
| Gross Profit | 64.85M |
| Operating Income | 20.64M |
| Pretax Income | 12.75M |
| Net Income | 12.69M |
| EBITDA | 25.18M |
| EBIT | 20.64M |
| Earnings Per Share (EPS) | $0.43 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 26.85M |
| Total Debt | 29.23M |
| Net Cash | -2.38M |
| Net Cash Per Share | -$0.08 |
| Equity (Book Value) | 46.59M |
| Book Value Per Share | 1.65 |
| Working Capital | 23.48M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 15.14M |
| Capital Expenditures | -403,000 |
| Depreciation & Amortization | 4.54M |
| Net Borrowing | -3.00M |
| Free Cash Flow | 14.73M |
| FCF Per Share | $0.52 |
Margins
| Measure | Value |
|---|
| Gross Margin | 61.41% |
| Operating Margin | 19.54% |
| Pretax Margin | 12.08% |
| Profit Margin | 12.02% |
| EBITDA Margin | 23.84% |
| EBIT Margin | 19.54% |
| FCF Margin | 13.95% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -11.94% |
| Shareholder Yield | -11.94% |
| Earnings Yield | 0.82% |
| FCF Yield | 0.99% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $71.50 |
| Price Target Difference | 37.03% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 56.36% |
| EPS Growth Forecast (3Y) | 118.76% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 5.28 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |